Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018020355) METHOD OF PREVENTING OR REDUCING THE INCIDENCE OF ACUTE URINARY RETENTION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/020355 International Application No.: PCT/IB2017/054277
Publication Date: 01.02.2018 International Filing Date: 14.07.2017
Chapter 2 Demand Filed: 23.05.2018
IPC:
A61K 38/10 (2006.01) ,A61K 31/517 (2006.01) ,A61P 13/02 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
04
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
10
Peptides having 12 to 20 amino acids
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
517
ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13
Drugs for disorders of the urinary system
02
of urine or of the urinary tract, e.g. urine acidifiers
Applicants:
NYMOX CORPORATION [US/US]; 777 Terrace Avenue Hasbrouck Heights, NJ 07604, US
Inventors:
AVERBACK, Paul; BS
Agent:
DOODY, Patrick A.; Pillsbury Winthrop Shaw Pittman LLP P.O. Box 10500 McLean, Virginia 22102, US
Priority Data:
15/222,36528.07.2016US
Title (EN) METHOD OF PREVENTING OR REDUCING THE INCIDENCE OF ACUTE URINARY RETENTION
(FR) PROCÉDÉ DE PRÉVENTION OU DE RÉDUCTION DE L'INCIDENCE DE LA RÉTENTION URINAIRE AIGUË
Abstract:
(EN) The embodiments include methods of preventing or reducing the incidence of acute urinary retention in mammals susceptible to developing acute urinary retention, and to methods of reducing the incidence of clinically detected prostate cancer, using compositions containing compounds based on small peptides and a pharmaceutically acceptable carrier. The method includes, but is not limited to, administering the compounds intramuscularly, orally, intravenously, intraprostatically, intrathecally, intratumorally, intranasally, topically, transdermally, etc., either alone or conjugated to a carrier to a mammal in need thereof.
(FR) Les modes de réalisation comprennent des procédés de prévention ou de réduction de l'incidence de la rétention urinaire aiguë chez les mammifères susceptibles de développer une rétention urinaire aiguë, et des procédés de réduction de l'incidence du cancer de la prostate détecté cliniquement, à l'aide de compositions contenant des composés à base de petits peptides et d'un vecteur pharmaceutiquement acceptable. Le procédé comprend, mais sans s'y limiter, une étape d'administration desdits composés par voie intramusculaire, orale, intraveineuse, intraprostatique, intrathécale, intratumorale, intranasale, topique, transdermique, etc., soit seuls, soit conjugués à un vecteur, à un mammifère nécessitant un tel traitement.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)